San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Nisen Named to CEO Post at Sanford-Burnham

HEALTH: He Sees Need for ‘Constellation’ Of New Relationships

Sanford-Burnham Medical Research Institute announced that the board of trustees has appointed Perry Nisen as CEO and holder of the Donald Bren chief executive chair for the institute’s La Jolla-based headquarters.

Tease photo

Platform Gives ERs a New Cardiac Device Tool

HEALTH: Co. Just Signed an Enterprise Deal With Sharp

Geneva Health Care Inc., a San Diego-based medical technology company has developed a platform that receives data from cardiac devices and converts it into usable information for health care providers. The data is presented in a dashboard that is integrated into the provider’s internal computer system so that physicians and medical staff can quickly identify the urgency of a patient’s needs.

Tease photo

Batu Biologics Completes $100,000 Crowdfunding

A San Diego-based immunotherapy company has successfully completed $100,000 of financing by utilizing an unusual fundraising approach — crowd funding.

Tease photo

Sanford-Burnham Medical Research Institute Names Nisen CEO

Sanford-Burnham Medical Research Institute’s board of trustees has appointed Perry Nisen as CEO and holder of the Donald Bren chief executive chair for the institute’s La Jolla-based headquarters.

Tease photo

Cytori Appoints Girão VP and CFO

San Diego-based Cytori Therapeutics Inc. announced that Tiago Girão has been appointed vice president and chief financial officer.

Tease photo

ResMed Sees New Devices Bridging Some Monitoring Divides

ResMed Inc. has released its new sleep apnea therapy device that will use patient data and communication software to help health care providers monitor and analyze their patients’ conditions.

Tease photo

CEO Gathered Leadership Lessons Along Unusual Career Path

HEALTH: Van Gorder’s Book Is About Building Up a Place and People

Chris Van Gorder has earned a reputation in San Diego as an influential leader in health care management, frequently receiving national attention for contributions to the profession. Now the Scripps Health CEO has permanently added his name in the history books of leadership and management by putting his name on the shelf with them.

Mirati Narrows Focus to Fewer Forms of Cancer

BIOTECH: FDA Grants Orphan Drug Status to Promising New Therapy

Mirati Therapeutics Inc., a public company in San Diego developing medicines for targeted oncology, is one step closer to achieving regulatory approval for its cancer drug Mocetinostat.

Tease photo

Ligand Signs Licensing Agreement With Georgia Company

Ligand Pharmaceuticals Inc. announced the signing of a commercial license agreement with Atlanta, Georgia-based Avion Pharmaceuticals LLC for the development and commercialization of four Captisol-enabled programs

Thermo Fisher Gets $9.1M Defense Deal, Work to Be Done in San Diego

The Defense Department said on Aug. 14 that it awarded a $9.1 million contract modification to Thermo Fisher Scientific to acquire reagents and consumables for its DNA Identification Laboratory at the Armed Forces Medical Examiners System at Dover Air Force Base in Delaware.

Tease photo

Shares Rise After Otonomy's $100M IPO

Shares of Otonomy Inc. were rising Aug. 13 after the biotech drug developer's initial public offering raised $100 million.

Tease photo

Cytori Therapeutics Nets $11.8M Loss for 2Q

Cytori Therapeutics Inc. reported a net loss of $11.8 million for second quarter 2014, down from a net loss $3.2 million during the same period in 2013.

Tease photo

Suffolk Completes $13 Million Family Health Center

The opening of the 23,000-square-foot medical office building was celebrated with a public event.

Tease photo

Scripps Research Names Paulson Acting President and CEO

The Scripps Research Institute appointed James Paulson, chair of its Department of Cell and Molecular Biology, as acting president and CEO, the institute’s board of trustees announced Monday.

Tease photo

Ligand to Offer $225 Million in Senior Convertible Notes, Authorizes $200M Share Buyback

San Diego-based Ligand Pharmaceuticals Inc. announced that it intends to offer $225 million of convertible senior notes due 2019 and has authorized a $200 million share repurchase program over the next 12 months.